Holds 2 valid CEPs for buprenorphine, filing since 2022. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 11 markets.
Holds one valid CEP for buprenorphine, filing since 2024. Its 2026 FDA inspection closed as VAI, and its GMP is recognised in 13 markets.
Holds 2 valid CEPs for buprenorphine, filing since 2023.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Open the full list with a free accountThis page filters the worldwide Buprenorphine manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free